UAG
WST icon

United Advisor Group’s West Pharmaceutical WST Stock Holding History

United Advisor Group’s Portfolio WST Stock Details WST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$200K Buy
+540
New +$191K 0.02% 551

Other funds holding WST

BlackRock
BlackRock New York $6.79T AUM 37.06% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.32T AUM 44.66% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.76T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.21T AUM
State Street
State Street Boston, Massachusetts $3.44T AUM 36.12% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $54.9B AUM 27.38% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $608B AUM 32.77% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.96T AUM 27.49% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.27T AUM 50.62% 1-Year Est. Return

United Advisor Group's WST Position: Q3 2026 in Review

United Advisor Group opened a new position in West Pharmaceutical (WST) in Q3 2026: 540 shares worth $200K. The stake represents 0.02% of the portfolio and ranks #551 among its holdings.

716 funds tracked by Wall St. Rank hold WST as of Q3 2026.

  • United Advisor Group held 540 shares of West Pharmaceutical worth $200K as of Q3 2026.
  • West Pharmaceutical was a new United Advisor Group position in Q3 2026.
  • West Pharmaceutical made up 0.02% of United Advisor Group's portfolio in Q3 2026, its #551 holding.
  • 716 funds tracked by Wall St. Rank held West Pharmaceutical as of Q3 2026.

Based on United Advisor Group's 13F filing for Q3 2026, filed 3 Nov 2026.